Suppr超能文献

环状 RNA 在肺动脉高压中的作用。

The role of circular RNAs in pulmonary hypertension.

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.

Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University, Stanford, CA, USA.

出版信息

Eur Respir J. 2022 Dec 1;60(6). doi: 10.1183/13993003.00012-2022. Print 2022 Dec.

Abstract

Circular RNAs (circRNAs) are endogenous, covalently circularised, non-protein-coding RNAs generated from back-splicing. Most circRNAs are very stable, highly conserved, and expressed in a tissue-, cell- and developmental stage-specific manner. circRNAs play a significant role in various biological processes, such as regulation of gene expression and protein translation sponging of microRNAs and binding with RNA-binding proteins. circRNAs have become a topic of great interest in research due to their close link with the development of various diseases. Their high stability, conservation and abundance in body fluids make them promising biomarkers for many diseases. A growing body of evidence suggests that aberrant expression of circRNAs and their targets plays a crucial role in pulmonary vascular remodelling and pulmonary arterial hypertension (group 1) as well as other forms (groups 3 and 4) of pulmonary hypertension (PH). Here we discuss the roles and molecular mechanisms of circRNAs in the pathogenesis of pulmonary vascular remodelling and PH. We also highlight the therapeutic and biomarker potential of circRNAs in PH.

摘要

环状 RNA(circRNAs)是一类内源性、共价闭环、无蛋白质编码的 RNA,由反向剪接产生。大多数 circRNAs 非常稳定、高度保守,并表现出组织、细胞和发育阶段特异性表达。circRNAs 在各种生物学过程中发挥着重要作用,如基因表达和蛋白质翻译的调控、miRNA 的海绵作用以及与 RNA 结合蛋白的结合。由于它们与各种疾病的发展密切相关,circRNAs 成为研究的热点。它们在体液中的高稳定性、保守性和丰度使它们成为许多疾病有前途的生物标志物。越来越多的证据表明,circRNAs 及其靶标的异常表达在肺血管重塑和肺动脉高压(第 1 组)以及其他形式(第 3 组和第 4 组)的肺动脉高压(PH)中起着关键作用。在这里,我们讨论了 circRNAs 在肺血管重塑和 PH 发病机制中的作用和分子机制。我们还强调了 circRNAs 在 PH 中的治疗和生物标志物潜力。

相似文献

1
The role of circular RNAs in pulmonary hypertension.环状 RNA 在肺动脉高压中的作用。
Eur Respir J. 2022 Dec 1;60(6). doi: 10.1183/13993003.00012-2022. Print 2022 Dec.
2
Circular RNAs Regulate Vascular Remodelling in Pulmonary Hypertension.环状 RNA 调控肺动脉高压中的血管重构。
Dis Markers. 2022 Nov 3;2022:4433627. doi: 10.1155/2022/4433627. eCollection 2022.
8
Circular RNAs: Promising Biomarkers for Human Diseases.环状 RNA:人类疾病有前途的生物标志物。
EBioMedicine. 2018 Aug;34:267-274. doi: 10.1016/j.ebiom.2018.07.036. Epub 2018 Aug 2.
10
Role of Circular RNAs in Pulmonary Fibrosis.环状 RNA 在肺纤维化中的作用。
Int J Mol Sci. 2022 Sep 10;23(18):10493. doi: 10.3390/ijms231810493.

引用本文的文献

9
Circular RNAs: emerging players in asthma and COPD.环状RNA:哮喘和慢性阻塞性肺疾病中的新兴参与者
Front Cell Dev Biol. 2023 Nov 24;11:1267792. doi: 10.3389/fcell.2023.1267792. eCollection 2023.

本文引用的文献

5
Promising therapeutic approaches in pulmonary arterial hypertension.肺动脉高压的有前途的治疗方法。
Curr Opin Pharmacol. 2021 Aug;59:127-139. doi: 10.1016/j.coph.2021.05.003. Epub 2021 Jun 30.
6
Noncoding RNA therapeutics - challenges and potential solutions.非编码 RNA 治疗学——挑战与潜在解决方案。
Nat Rev Drug Discov. 2021 Aug;20(8):629-651. doi: 10.1038/s41573-021-00219-z. Epub 2021 Jun 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验